SEO URLwww.firestrike.ai/deals/arthrosi-therapeutics-sobi-acquisition-2026
acquisitionAnnounced · Jan 5, 2026BiotechnologySource · MagazinesArticle · Factual
Sobi acquires Arthrosi Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$950M
Target
Arthrosi Therapeutics
Acquirer
Sobi
Full Acquisition
Status
Pending
Sobi agreed to acquire Arthrosi Therapeutics. Reported deal value: $950M. Status: Pending. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-05. Figures and status may change as filings and press coverage update.
Published Category Biotech Latest News Sobi has entered into a definitive agreement to acquire Arthrosi Therapeutics , a late-stage biotechnology company developing a next-generation oral therapy for gout
Deal timeline
Announced
Jan 5, 2026 · thehealthcaretechnologyreport.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $950M. Figures and status may change as sources update.
Sources: thehealthcaretechnologyreport.com · Primary article · FireStrike proprietary index